Clinical Trial Update: Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies

View source ↗

Summary

Completed analyses from UK Biobank and a Chinese single-center database suggest that use of 5-alpha reductase inhibitors may be associated with reduced risk of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Benign Prostatic Hyperplasia

Drugs mentioned

• DUTASTERIDE (Dutasteride)
• FINASTERIDE (FINASTERIDE)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Benign Prostatic Hypertrophy (BPH) | Status: COMPLETED